{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Disc Medicine, Inc."},"Symbol":{"label":"Symbol","value":"IRON"},"Address":{"label":"Address","value":"United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism."},"CompanyUrl":{"label":"Company Url","value":"https://www.discmedicine.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"John D. Quisel","title":"President, Chief Executive Officer & Director"},{"name":"Melanie Chin","title":"VP-Clinical Development & Head-Medical Affairs"},{"name":"Rahul Rajan Kaushik","title":"Chief Technical Officer"},{"name":"William Savage","title":"Chief Medical Officer"},{"name":"Yen Wen Yu","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}